Patents by Inventor Andrew Sharabi

Andrew Sharabi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CANCER ACTIVITY OF ADAMANTANE DERIVATIVES
    Publication number: 20240065987
    Abstract: Provided herein are methods for treating cancer comprising administering to a subject in need thereof an adamantane derivative, or a pharmaceutically acceptable salt thereof, such as rimantadine or amantadine. In some embodiments, the adamantane derivative is PEGylated.
    Type: Application
    Filed: October 24, 2023
    Publication date: February 29, 2024
    Inventor: Andrew Sharabi
  • ANTI-CANCER ACTIVITY OF ADAMANTANE DERIVATIVES
    Publication number: 20210330605
    Abstract: Provided herein are methods for treating cancer comprising administering to a subject in need thereof an adamantane derivative, or a pharmaceutically acceptable salt thereof, such as rimantadine or amantadine. In some embodiments, the adamantane derivative is PEGylated.
    Type: Application
    Filed: December 5, 2019
    Publication date: October 28, 2021
    Inventor: Andrew Sharabi
  • Modulation of negative immune regulators and applications for immunotherapy
    Patent number: 7868159
    Abstract: The invention includes compositions and methods for enhancing immunopotency of an immune cell by way of inhibiting a negative immune regulator in the cell. The present invention provides vaccines and therapies in which antigen presentation is enhanced through inhibition of negative immune regulators. The present invention also provides a mechanism to break self tolerance in tumor vaccination methods that rely on presentation of self tumor antigens.
    Type: Grant
    Filed: January 19, 2006
    Date of Patent: January 11, 2011
    Assignee: Baylor College of Medicine
    Inventors: Si-Yi Chen, Kevin C. Evel-Kabler, Xiaotong Song, Xue F. Huang, Andrew Sharabi
  • Modulation of negative immune regulators and applications for immunotherapy
    Publication number: 20060292119
    Abstract: The invention includes compositions and methods for enhancing immunopotency of an immune cell by way of inhibiting a negative immune regulator in the cell. The present invention provides vaccines and therapies in which antigen presentation is enhanced through inhibition of negative immune regulators. The present invention also provides a mechanism to break self tolerance in tumor vaccination methods that rely on presentation of self tumor antigens.
    Type: Application
    Filed: January 19, 2006
    Publication date: December 28, 2006
    Inventors: Si-Yi Chen, Kevin Evel-Kabler, Xiaotong Song, Xue Huang, Andrew Sharabi